Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

NCT07274254 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07274254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
July 3, 2026
Completion date
August 3, 2028
Enrollment
104 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

vaso-occlusive pain episode in sickle cell disease